Bellerophon Therapeutics Inc (BLPH)
0.0541
0.00 (0.00%)
USD |
OTCM |
Apr 24, 16:00
Bellerophon Therapeutics Shareholders Equity (Quarterly): 3.723M for Sept. 30, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 3.723M |
| June 30, 2023 | 5.623M |
| March 31, 2023 | 10.60M |
| December 31, 2022 | 2.534M |
| September 30, 2022 | 7.428M |
| June 30, 2022 | 12.28M |
| March 31, 2022 | 16.17M |
| December 31, 2021 | 21.62M |
| September 30, 2021 | 25.79M |
| June 30, 2021 | 30.10M |
| March 31, 2021 | 33.13M |
| December 31, 2020 | 38.25M |
| September 30, 2020 | 45.87M |
| June 30, 2020 | 53.40M |
| March 31, 2020 | 2.146M |
| December 31, 2019 | 3.591M |
| September 30, 2019 | 7.349M |
| June 30, 2019 | 11.46M |
| March 31, 2019 | 10.30M |
| Date | Value |
|---|---|
| December 31, 2018 | 3.856M |
| September 30, 2018 | 3.927M |
| June 30, 2018 | -7.775M |
| March 31, 2018 | 2.217M |
| December 31, 2017 | -2.594M |
| September 30, 2017 | 15.67M |
| June 30, 2017 | -0.787M |
| March 31, 2017 | 0.80M |
| December 31, 2016 | 17.99M |
| September 30, 2016 | 18.00M |
| June 30, 2016 | 20.06M |
| March 31, 2016 | 23.90M |
| December 31, 2015 | 30.34M |
| September 30, 2015 | 40.52M |
| June 30, 2015 | 51.22M |
| March 31, 2015 | 62.39M |
| December 31, 2014 | 22.94M |
| September 30, 2014 | 35.10M |
| December 31, 2013 | -15.74M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
2.146M
Minimum
Mar 2020
53.40M
Maximum
Jun 2020
18.39M
Average
11.87M
Median
Shareholders Equity (Quarterly) Benchmarks
| Janux Therapeutics Inc | 344.35M |
| NovaBay Pharmaceuticals Inc | 3.314M |
| Palatin Technologies Inc | -11.38M |
| iBio Inc | 9.197M |
| Theriva Biologics Inc | 39.70M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.979M |
| Total Liabilities (Quarterly) | 1.256M |